| Protein HESylation for half-life extension: synthesis, characterization and pharmacokinetics of HESylated anakinra R Liebner, R Mathaes, M Meyer, T Hey, G Winter, A Besheer European Journal of Pharmaceutics and Biopharmaceutics 87 (2), 378-385, 2014 | 90 | 2014 |
| Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated anakinra R Liebner, M Meyer, T Hey, G Winter, A Besheer Journal of Pharmaceutical Sciences 104 (2), 515-526, 2015 | 32 | 2015 |
| Challenges for PEGylated proteins and alternative half-life extension technologies based on biodegradable polymers A Besheer, R Liebner, M Meyer, G Winter Tailored polymer architectures for pharmaceutical and biomedical …, 2013 | 19 | 2013 |
| Freeze-drying of HESylated IFNα-2b: Effect of HESylation on storage stability in comparison to PEGylation R Liebner, S Bergmann, T Hey, G Winter, A Besheer International Journal of Pharmaceutics 495 (1), 608-611, 2015 | 10 | 2015 |
| Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications; Scholz, C., Kressler, J., Eds A Besheer, R Liebner, M Meyer, G Winter ACS Symposium Series 1135, 215, 0 | 4 | |
| Formulation of PEGylated and HESylated biopharmaceuticals R Liebner lmu, 2015 | | 2015 |
| Chapter III–Highly concentrated formulations R Liebner, M Meyer, T Hey, G Winter, A Besheer | | |
